Axsome Therapeutics (AXSM) PT Raised to $202 at Wells Fargo
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Price: $207.77 -0.12%
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Wells Fargo analyst Benjamin Burnett raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $202.00 (from $193.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
